Cargando…

The natural history of primary progressive multiple sclerosis: insights from the German NeuroTransData registry

BACKGROUND: Primary progressive multiple sclerosis (PPMS) is characterised by gradual worsening of disability from symptom onset. Knowledge about the natural course of PPMS remains limited. METHODS: PPMS patients from the German NeuroTransData (NTD) MS registry with data from 56 outpatient practices...

Descripción completa

Detalles Bibliográficos
Autores principales:	Braune, Stefan, Bluemich, Sandra, Bruns, Carola, Dirks, Petra, Hoffmann, Jeanette, Heer, Yanic, Rouzic, Erwan Muros-Le, Bergmann, Arnfin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320981/ https://www.ncbi.nlm.nih.gov/pubmed/37407914 http://dx.doi.org/10.1186/s12883-023-03273-9

Ejemplares similares

The socioeconomic impact of disability progression in multiple sclerosis: A retrospective cohort study of the German NeuroTransData (NTD) registry
por: Dillon, Paul, et al.
Publicado: (2023)

Comparative effectiveness of delayed-release dimethyl fumarate versus interferon, glatiramer acetate, teriflunomide, or fingolimod: results from the German NeuroTransData registry
por: Braune, Stefan, et al.
Publicado: (2018)

How do patients with secondary progressive multiple sclerosis enrolled in the EXPAND randomized controlled trial compare with those seen in German clinical practice in the NeuroTransData multiple sclerosis registry?
por: Braune, Stefan, et al.
Publicado: (2022)

Impact of drug diversity on treatment effectiveness in relapsing-remitting multiple sclerosis (RRMS) in Germany between 2010 and 2018: real-world data from the German NeuroTransData multiple sclerosis registry
por: Braune, Stefan, et al.
Publicado: (2021)

COVID-19: Status neurologischer und psychiatrischer Praxen am Beispiel des Netzwerks NeuroTransData
por: Bergmann, Arnfin
Publicado: (2020)

Implementation of a data control framework to ensure confidentiality, integrity, and availability of high-quality real-world data (RWD) in the NeuroTransData (NTD) registry
por: Wehrle, Knut, et al.
Publicado: (2022)

Overall and patient-specific comparative effectiveness of dimethyl fumarate versus teriflunomide: A novel approach to precision medicine applied to the German NeuroTrans Data Multiple Sclerosis Registry
por: Jiang, Xiaotong, et al.
Publicado: (2023)

PHREND(®)—A Real-World Data-Driven Tool Supporting Clinical Decisions to Optimize Treatment in Relapsing-Remitting Multiple Sclerosis
por: Braune, Stefan, et al.
Publicado: (2022)

Safety, Adherence and Persistence in a Real-World Cohort of German MS Patients Newly Treated With Ocrelizumab: First Insights From the CONFIDENCE Study
por: Weber, Martin S., et al.
Publicado: (2022)

Development of Registry Data to Create Interactive Doctor-Patient Platforms for Personalized Patient Care, Taking the Example of the DESTINY System
por: Bergmann, Arnfin, et al.
Publicado: (2021)

Understanding the impacts of COVID-19 pandemic in people with multiple sclerosis treated with ocrelizumab
por: Pedotti, Rosetta, et al.
Publicado: (2021)

Cas d’infection à la COVID-19 chez des personnes atteintes de sclérose en plaques (SEP) traitées par ocrelizumab (OCR) : actualisation des données de pharmacovigilance
por: Hughes, Richard, et al.
Publicado: (2021)

Second line use of Fingolimod is as effective as Natalizumab in a German out-patient RRMS-cohort
por: Braune, Stefan, et al.
Publicado: (2013)

The Danish Neuro-Oncology Registry
por: Hansen, Steinbjørn
Publicado: (2016)

Electronic health record data for assessing risk of hospitalization for COVID-19: Methodological considerations applied to multiple sclerosis
por: Dillon, Paul, et al.
Publicado: (2023)

B-Cell Activity Predicts Response to Glatiramer Acetate and Interferon in Relapsing-Remitting Multiple Sclerosis
por: Tacke, Sabine, et al.
Publicado: (2021)

Orthopaedic registries: the German experience
por: Jansson, Volkmar, et al.
Publicado: (2019)

Clinical outcomes of COVID-19 in patients with multiple sclerosis treated with ocrelizumab in the pre- and post-SARS-CoV-2 vaccination periods: Insights from Israel
por: Weberpals, Janick, et al.
Publicado: (2022)

The Danish Neuro-Oncology Registry: establishment, completeness and validity
por: Hansen, Steinbjørn, et al.
Publicado: (2016)

The German National Registry of Primary Immunodeficiencies (2012–2017)
por: El-Helou, Sabine M., et al.
Publicado: (2019)

Analysis of revision shoulder arthroplasty in the German nationwide registry from 2014 to 2018
por: Kircher, Jörn, et al.
Publicado: (2021)

NeuroTransDB: highly curated and structured transcriptomic metadata for neurodegenerative diseases
por: Bagewadi, Shweta, et al.
Publicado: (2015)

The German Hemophilia Registry: Growing with Its Tasks
por: Duda, Heike, et al.
Publicado: (2020)

Risk of requiring a wheelchair in primary progressive multiple sclerosis: Data from the ORATORIO trial and the MSBase registry
por: Butzkueven, Helmut, et al.
Publicado: (2021)

A Neuro-Informatics Pipeline for Cerebrovascular Disease: Research Registry Development
por: Potter, Thomas B H, et al.
Publicado: (2023)

Ablation of Atrial Fibrillation in Patients with Hypertension—An Analysis from the German Ablation Registry
por: Zylla, Maura M., et al.
Publicado: (2020)

German Cranial Reconstruction Registry (GCRR): protocol for a prospective, multicentre, open registry
por: Giese, Henrik, et al.
Publicado: (2015)

The German Aortic Valve Registry (GARY): in-hospital outcome
por: Hamm, Christian W., et al.
Publicado: (2014)

Structure and establishment of the German Cochlear Implant Registry (DCIR)
por: Stöver, T., et al.
Publicado: (2023)

Sex Differences in Percutaneous Coronary Intervention—Insights From the Coronary Angiography and PCI Registry of the German Society of Cardiology
por: Heer, Tobias, et al.
Publicado: (2017)

First Results from the Prospective German Registry for Childhood Glaucoma: Phenotype–Genotype Association
por: Stingl, Julia V., et al.
Publicado: (2021)

Histological criteria for atypical pituitary adenomas – data from the German pituitary adenoma registry suggests modifications
por: Miermeister, Christian P., et al.
Publicado: (2015)

The NeuroAiD Safe Treatment (NeST) Registry: a protocol
por: Venketasubramanian, Narayanaswamy, et al.
Publicado: (2015)

Epidemiological comparison between the Navarra Major Trauma Registry and the German Trauma Registry (TR-DGU®)
por: Ali Ali, B., et al.
Publicado: (2017)

Predictors of Atrial Fibrillation Recurrence after Catheter Ablation: Data from the German Ablation Registry
por: Sultan, A., et al.
Publicado: (2017)

Drug anaphylaxis in children – data of the German-speaking anaphylaxis registry
por: Gernert, S, et al.
Publicado: (2013)

The German Lipoprotein Apheresis Registry (GLAR) – almost 5 years on
por: Schettler, V. J. J., et al.
Publicado: (2017)

First report from the German COVID-19 autopsy registry
por: von Stillfried, Saskia, et al.
Publicado: (2022)

German Cardiac Arrest Registry: rationale and design of G-CAR
por: Pöss, Janine, et al.
Publicado: (2022)

Framework for personalized prediction of treatment response in relapsing remitting multiple sclerosis
por: Stühler, E., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gp5ngv727p8315mn8p4s8ad1uh